Navigation Links
Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
Date:7/1/2008

is supported by an educational grant from ViroPharma Incorporated.

Robert Michael Educational Institute LLC is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers, patients, and caregivers. Our mission is to design programs that improve diagnosis and treatment through a variety of educational programming such as national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit http://www.RMEI.com.

(1) McFarland LV, Surawicz CM, Rubin M, et al. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol. 1999;20:43-50.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
3. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
4. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
5. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
6. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
7. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
8. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
9. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
10. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
11. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,presented data at the ...es,in Cancer in Washington, D.C., announcing the d... that demonstrate significant anticancer,activity ...molecular scaffold has been developed using,comput...3 kinase inhibitors,as well as isoform-selective s...
(Date:8/26/2008)...FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today a...,from the CUSTOM II trial was published in the mos...ntervention. The lead author of the article was,Dr...nter Utrecht, Utrecht,The Netherlands on behalf o...es across Europe., The one-year CUSTOM II trial, ...
(Date:8/25/2008)...nt Strategies--, PHILADELPHIA, Aug. 25 /PRNewswir...utations that are the main cause of the inherited ...addition, the researchers found,that the same muta...f,non-inherited neuroblastoma, the more common for...offer the first genetic tests to families,affected...
(Date:8/25/2008)...d Japanese Development Studies ...25 /- Genmab has,announced ...ic lymphocytic,leukemia and non-Hodgkin,s lymphoma... begin four studies of,ofatumumab in chronic lymph... lymphoma (NHL) this year., "Genmab and GSK have ...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Study finds no connection between vitamin D and overall cancer deaths 5032 1Study finds no connection between vitamin D and overall cancer deaths 5032 2Going live with click chemistry 1040 1Going live with click chemistry 1040 2Going live with click chemistry 1040 3Could hairy roots become biofactories 3F 1036 1Could hairy roots become biofactories 3F 1036 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 1Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 3
... data From 741-patient Trial Show Those Treated wi...mpact on Blood Pressure Compared,to Ibuprofen, EAS...ients with,osteoarthritis who also have controlled...rage daily blood pressure when treated with,the in...b compared,to a slight increase in those taking ib...
... Data to be Presented at the European League Again...tential Benefit of ofatumumab,in Patients With Rhe...Pennsylvania and COPENHAGEN,Denmark, June 15, 200...and Genmab A/S (CSE: GEN) announced today positive...be presented at EULAR,2007, the Annual European Co...
Other Medicine Technology:Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...nataka is planning to enact legislation to make HI...d for politicians seeking to enter the state legis...ment on the need to bring in such a legislation wi...R. Ashok told IANS. Karnataka is one of six high-p...
...ers Novartis, is filing a petition against a court... its anti-cancer drugs. // What makes this news si...uality of life for an AIDS patient; a nightmare or... is backing its right to patent a modified version...
...en who wear a special kind of no-line bifocal lens... those who wear more conventional lenses according...ssue of Investigative Ophthalmology & Visual Scien...ng children with two myopic parents, myopia progre...
...al study led by Johns Hopkins suggests that the ra...haran Africa that HIV dementia along with Alzheime...ng the most common forms of dementia in the world....n the African continent using rigorous neurologica...
Other Medicine News:Health News:HIV Tests to Be Made Mandatory for Karnataka Couples, Politicians 2Health News:To Patent or Not-A Question of Life 2Health News:HIV Dementia Alarmingly High in Africa 2
LabWeb is a full-featured laboratory information system (LIS) with the added benefits only Psyche Systems can deliver - high ROI, a secure hosted offering and a true partnership. LabWeb features adva
LabPak POL Plus 2 Laboratory Information System
...e surgeon to view the patient, c-arm image intensi...ile field. , ,Electrocautery Cord and suction Tub...ng longer cord length sterility. , ,Extra large f...mmodates the larger incise area and can improve as...
...ealth will change the way you think about drapes a...and reduced reimbursements mean costs must be care... the quality of care or jeopardizing patient outco...pective of total value and long-term implications....
Medicine Products: